SCHEMBL8570415

SCHEMBL8570415

CCN(CC)C(=O)/C=C(\C)c1ccc(SCCc2ccccc2)c(O)c1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 20/20 0.58
LTB4R2 Q9NPC1 20/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8570246 0.80 LTB4R (0.69) LTB4RLTB4R2
SCHEMBL8599326 0.80 LTB4R (0.69) LTB4RLTB4R2
SCHEMBL8420032 0.79 LTB4R (0.66) LTB4RLTB4R2
SCHEMBL7986719 0.79 LTB4R (0.66) LTB4RLTB4R2
SCHEMBL7976153 0.79 LTB4R (0.66) LTB4RLTB4R2
SCHEMBL8422443 0.76 LTB4R (0.60) LTB4RLTB4R2
SCHEMBL7987593 0.74 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7987594 0.74 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7987586 0.74 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL8418446 0.72 LTB4R (0.65) LTB4RLTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0942903-A1 ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY Novartis AG (CH) 1999-09-22 EP disclosed
WO-1998013347-A1 ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY NOVARTIS AG (CH) 1998-04-02 WO disclosed